InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Larkin Cristina, Chief Operating Officer. Officer active across 1 companies, notably Spero Therapeutics, Inc.. Cumulatively, 4 filings have been recorded. The latest transaction was disclosed on 1 February 2022 — Attribution. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations4 total
038,014 shares0
Common Stock
SEC:0000899243-22-004592:0·
038,014 shares0
Common Stock
SEC:0000899243-22-004592·
024,067 shares0
Common Stock
SEC:0000899243-21-034501·
024,067 shares0
Common Stock
SEC:0000899243-21-034501:0·
4 of 4 declarations
About Larkin Cristina
Cristina Larkin is the Chief Operating Officer at Spero Therapeutics, Inc. She is responsible for the daily management of the company's operations, ensuring that processes are efficient and aligned with strategic objectives. With expertise in operational management, she plays a key role in optimizing performance and supporting innovation within Spero Therapeutics. Her leadership is essential for the company's success.
